Multidisciplinary Approach to Understanding Cytomegalovirus Diseases
Proceedings of the Fourth International Cytomegalovirus Workshop - Multidisciplinary Approaches to Understanding CMV Disease, Paris, France, 19-21 April 1993
Published in August 1993
Book
Hardback
364 pages
978-0-444-81699-3 (ISBN)
Description
CMV increases in importance each year, due to the growing number of immunosuppressed individuals and the natural desire that every pregnancy has an optimal outcome. Interest in this infectious agent is international, as evidenced by the nearly 300 participants who attended the conference.
CMV increases in importance each year, due to the growing number of immunosuppressed individuals and the natural desire that every pregnancy has an optimal outcome. Interest in this infectious agent is international, as evidenced by the nearly 300 participants who attended the conference.
CMV increases in importance each year, due to the growing number of immunosuppressed individuals and the natural desire that every pregnancy has an optimal outcome. Interest in this infectious agent is international, as evidenced by the nearly 300 participants who attended the conference.
More details
Series
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
Professional and scholarly
Illustrations
indexes
Dimensions
Height: 230 mm
Weight
834 gr
ISBN-13
978-0-444-81699-3 (9780444816993)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Viral genome: Regulation of transcription from the cytomegalovirus major immediate early promoter by cellular and viral proteins, M.F. Stinksi et al; Role of CCAAT box-binding protein in an early promoter activation of human cytomegalovirus, L. Huang, C. Malone, M-F. Stinski. Viral proteins: Human cytomegalovirus encoded proteins - Application of basic research to the diagnosis and treatment of HCMV infection, W. Britt et al; Mutational analysis of antigenic domain 1 (AD-1) of glycoprotein GP58 of human cytomegalovirus, E. Hassfurther, W. Britt, M. Mach. Workshop on nomenclature of CMV genes and proteins - An overview: Human cytomegalovirus structural proteins - A report of the first nomenclature workshop, M.-P. Landini, R.R. Spaete. Latency and reactivation: Dependence of cytomegalovirus replication on monocyte differentiation, J.A. Nelson et al; Monocyte-mediated transmission of infectious cytomegalovirus among human endothelial monolayers - An in vitro model of virus dissemination, W.J. Waldman, D.A. Knight, D.D. Sedmak. Cytokines: Reactivation of murine cytomegalovirus from latency, R.D. Cardin el al; Induction of cytokines by human cytomegalovirus, S.St. Jeor et al. Components of the immune response to CMV: Components of the immune response, M.J. Reddehase, P. Lucin; Lymphocyte-mediated cytotoxicity of endothelial cells infected with cytomegalovirus - Role in graft rejection, A. Weinberg, L. Zhang, R.M. Tuder. Immune deficiencies and CMV: High incidence of CMV infection following pancreas transplantation, C. Lumbreras et al; Maternal viremia and congenital CMV infection, K.B. Balcarek, M.K. Oh, R.F. Pass. Diagnostic techniques: Molecular diagnostic techniques for CMV infection, S. Chou. PCR: Cytomegalovirus pathogenesis - Applications of PCR, V.C. Emery. Workshop on diagnostic criteria for CMV disease - An overview: Definitions of cytomegalovirus infection and disease, P. Ljungman, P. Griffiths. Antivirals today: Antivirals for cytomegalovirus, R.A. Bowden; Survival benefit with acyclovir in a controlled trial in AIDS patients, P.D. Griffiths. Antivirals tomorrow: Strategies for the treatment of cytomegalovirus infections, R. Snoeck, J. Neyts, E. de Clercq; Efficacy of HPMPC in the treatment of CMV infections in various animal models, J. Neyts et al. Passive immune therapy: The generation of human anti-cytomegalovirus monoclonal antibodies against the lower matrix protein pp65 and the p52 nuclear DNA-binding phosphoprotein, J. van Zanten et al. Vaccines: Progress in the development of a human cytomegalovirus glycoprotein subunit vaccine, L. Rasmussen; Immunogenetics of the human T cell response to HCMV, H. He, C.R. Rinaldo Jr, P.A. Morel. Workshop on immunological interventions in CMV: Summary of workshop on immunological interventions, S.A. Plotkin, U. Koszinowski. (Part contents).